Member Info for PM2022

PYC agreement to finish next week as well. We are due an update on this as well and this is likely to come next week. Looks like a great end of year here.

Almost certain we will get the official deal come through before the meeting to avoid misunderstandings. This will explode.

Looking forward to a transformational end to the year. Not long left.

Stop using misleading titles that gives these idiots the attention they want. Might help thanks.

American guys are very proactive and they would have had all the funding sorted out. Can see the official RNS coming out towards the end of the month which could rock the market at this low market cap. Nice 7-8% royalties as well.

Fully funded for the next 2 years. All looks amazing and a great entry point here.

Totally agree Waynesmith we should settle much higher once the official deal comes through. I have a feeling Cenkos will bring in some big buyers maybe in the 10% range because they have an incentive to increase the SP. It should increase confidence as well.

These are the times to get the greatest value for what lies ahead. 5-10 bagger in the next 6 months to 1 year imo if we add another one or two deals.

I multitask IAR and have other things to do at the same time unlike you with nothing better to do than to be on a board that you claim to be invested in. Val is my only investment and when I am finished that will be the intention.

Get over your previous sacking from Val and move on sunshine.

I am hearing some whispers a few big buyers are loading up here.

Good luck all should see 40s in the coming days.

Big buyers are buying here. Only way is up at this level. Shorters will get burnt soon.

Looks like we need institutional investors as soon as possible. This type of manipulation by many is poor but not worried. These types of moves are temporary we should head back up significantly in 2-3 weeks leading into the deal RNS.

For now this is buy level. Buy low sell high this is very low at the moment.

Forget trading these are the times you buy not when it goes up. This will multi bag in the coming months we just have to be patient. Anyway we got funding news and official deal RNS to come soon so we should go back up. At less than 20 million we are significantly undervalued and currently imo we should be 80p plus and market cap of 50 million. As I said Institutional investors will fill the gaps in the coming months and Cenkos are also in this with us so Val will go up imo.

Not worried at all as my average price is 20p and I am buying a few more here.

We should bounce from here. Official deal RNS to come which will get people jumping in if we are where we are.

Lots of orders at 30p so I would buy a little earlier like now.

IAR,

Few ignorant people here that are not able to think beyond AZ. Do research on the US market and how funding for drugs works in the US and the advantages of this type of process. Also do some research on the skills of the people that will be leading this project. Pass phase 2b and the drug will be worth 100 million plus. Get a few indications in as well. Don't forget the royalties likely to be 7-8%. Also regular updates from Suzy who will actively be involved. No more spoon feeding IAR so please keep up.

All that without mentioning anything else such as other deals and we will be having institutional investors joining us soon to fill any gaps in the SP. At a market cap of 20 million it is a buy with significant short, mid and long term upside.

Next year lol.

Baldy, more likely you will see your 236p quicker than if we had an AZ or Merck imo. Lets pass phase 2b quickly with the right dataset and with a better chance of success with a few further indications coming through or get a second deal or get one of those preclinical drugs sold on. Institutional investors jumping on board to fill any gaps and we may well see that 236p this year.

All looking great with a brilliant team on board for 201 and nice royalties for when we get to market all for a current market cap of 20 million odd at the moment. No brainer.

Porky is cool and good to have on this board. The problem is the select 3 or 4 individuals that put out false rumours on the RNS day. We are oversold and the deal is a decent one but with lower than expected upfront payments. If a few were disappointed with the upfront payment then it is important to remember our working capital is covered and our strategy does not involve doing clinical trials. Therefore it does not matter very much the bigger picture is what counts and should be reflected in the current market cap but is not.

The startup company that a few mention is a common investment vehicle in the US and a very successful one. We have a prostate cancer specialist, patent attorney and a peptide specialist. What a team and they will bring the best value at the fastest speed and will do everything they can to get this to the market as fast as possible.

IMO at this moment of time we should be 80p plus and we are oversold. Hopefully confirmation of funding and the deal next month will take us close to that value.

Again worth sharing Iceman's Sunday Roast interview 57 min onwards. For me this represents a brilliant risk to reward ratio with so much to come in the coming months and if all fails then institutional investors will fill the gap by Cenkos who also have an incentive to get us going.

https://podcasts.apple.com/gb/podcast/the-sunday-roast/id1593750832?i=1000541009563

For those that never had a chance to listen to the interview during the week. Official deal RNS due later this month/ next month with confirmation of funding.

https://audioboom.com/posts/7973052-midweek-takeaway-with-valirx-ceo-suzy-dilly

All relative to the current market cap of 22 million which is massively undervalued. Once the final deal and confirmation of funds come through end of this month or next month then we will be heading up.

This is buy level not sell. Ignore the day to day movements I would say. Will be looking to buy more today.

IAR looks like you lost your touch over the months.

Desperation to get in for people like you. Good luck and keep praying. Losers will be losers.

A few maybe panicking. I would ask that we consider downside vs upside here. Our market cap is only 22 million.

No Placing for years if all goes to plan
Deal for VAL 201 potentially worth 100s millions
301 endermotosis significant pre-clinical work being done both with the Japanese the last 18 months. Deal possible anytime.
401 actively in discussions regarding a deal
Breast Cancer drug being worked on to hopefully be sold on as a pre-clinical drug
New projects coming in to be sold for millions with a decent speed for completion
Cenkos have a significant interest in the business and will make big money if VAL goes up

When being fearful always good to go the other way as long as you can hold. Provided you see potential and a low market cap it would normally be a great hold and buy. Sentiment will change week by week. I will be holding and adding where I can as for me this is an opportunity to add.

If in doubt watch the interview from last night. Best of luck and ignore the trolls here they are itching to get in.

https://audioboom.com/posts/7973052-midweek-takeaway-with-valirx-ceo-suzy-dilly

So we end up with a board full of n*** who don't bother doing any research or watching the interview. All this was addressed.

Every company has an if or a but but here the probability of success or upside is the best in AIM with limited to no long term downside imo when considering all relevant factors. As always DYOR and ignore these trolls.

https://audioboom.com/posts/7973052-midweek-takeaway-with-valirx-ceo-suzy-dilly